Suppliers

Press Release CHARLOTTE, NC, March 19, 2026 - Clariant is expanding its Clear Lake site to include excipient GMP-compliant manufacturing...

Abstract Objectives: The current study presents a sequential strategy for the development of directly compressible powder formulations relying on Design...

See our next webinar on the topic of: Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug...

This poster has been presented at the  15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology  which took place in...

Abstract Kollidon® SR of low (KoL) or high (KoH) moisture content was hot-melt extruded with sorbitol (SOR). Microhardness of KoL/SOR...

Abstract Purpose This research was designed to systematically investigate the performance of three lactose-based co-processed excipients (CPEs): SuperTab® 40LL, StarLac®, and...

Abstract Insufficient aqueous dissolution properties constitute a fundamental barrier impacting approximately 40% of commercialized and 90% developmental pharmaceuticals, significantly limiting...

Abstract Background/Objectives: Meloxicam (MLX) is a nonsteroidal anti-inflammatory drug (NSAID) recommended for treating acute and chronic pain in dogs, frequently...

High purity amino acids for bioprocessing and formulation Amino acids are the fundamental building blocks of proteins and play a...

Abstract Bulk density (ρb) serves as a fundamental powder parameter across various industries. In the pharmaceutical industry, its implications on...